Point72 Asia (Singapore)’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,699
Closed -$121K 1158
2024
Q3
$121K Sell
2,699
-11,857
-81% -$534K 0.02% 494
2024
Q2
$504K Buy
+14,556
New +$504K 0.11% 155